Losartan Potassium Tablet, Film Coated
Product Images NDC 70518-2316

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 70518-2316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losartan Potassium 50mg 70518 2316 01

Losartan Potassium 50 mg tablets, manufactured by Aurobindo Pharma Ltd. in India, are packaged by Orépack with a quantity of 30 tablets. It is a prescription medication with NDC# 70518-2316-01. The storage instructions advise keeping it between 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F). The package insert should be consulted for further directions for use, and the medication should be kept out of the reach of children. Repackaging has been done by Remedy Repack Inc. in Indiana.*

FDA Label Image

Figure1 (Losartan Fig1)

This text refers to two medications: Atenolol and Losartan Potassium. It mentions an "Adjusted Risk Reduction" of 13% with study months shown in the format of intervals from 6 to 66.*

FDA Label Image

Figure2 (Losartan Fig2)

This text provides information on the drugs Atenolol and Losartan Potassium. It seems to show data related to the percentage of patients experiencing fatal/non-fatal strokes over a period of 66 months in a study.*

FDA Label Image

Figure 3 (Losartan Fig3)

FDA Label Image

Figure-4 (Losartan Fig4)

The text is not readable.*

FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.